H. Nagao

564 total citations
10 papers, 461 citations indexed

About

H. Nagao is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, H. Nagao has authored 10 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in H. Nagao's work include Hedgehog Signaling Pathway Studies (3 papers), Tumors and Oncological Cases (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). H. Nagao is often cited by papers focused on Hedgehog Signaling Pathway Studies (3 papers), Tumors and Oncological Cases (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). H. Nagao collaborates with scholars based in Japan and France. H. Nagao's co-authors include Setsuro Komiya, Takao Setoguchi, Masataka Hirotsu, Hiromi Sasaki, Yasuhiro Ishidou, Satoshi Nagano, Takuya Yamamoto, Hui Gao, Masahisa Jinushi and Hironori Yoshiyama and has published in prestigious journals such as Immunity, PLoS ONE and British Journal of Cancer.

In The Last Decade

H. Nagao

10 papers receiving 457 citations

Peers

H. Nagao
Phuong N. Le United States
J. Jason Morton United States
Joanna E. Richards United States
K-H Heider Austria
Carmel M.T. Horgan United Kingdom
Phuong N. Le United States
H. Nagao
Citations per year, relative to H. Nagao H. Nagao (= 1×) peers Phuong N. Le

Countries citing papers authored by H. Nagao

Since Specialization
Citations

This map shows the geographic impact of H. Nagao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Nagao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Nagao more than expected).

Fields of papers citing papers by H. Nagao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Nagao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Nagao. The network helps show where H. Nagao may publish in the future.

Co-authorship network of co-authors of H. Nagao

This figure shows the co-authorship network connecting the top 25 collaborators of H. Nagao. A scholar is included among the top collaborators of H. Nagao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Nagao. H. Nagao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Suzuki, M., H. Nagao, Y. Harada, et al.. (2020). Raw-to-repository characterization data conversion for repeatable, replicable, and reproducible measurements. Journal of Vacuum Science & Technology A Vacuum Surfaces and Films. 38(2). 9 indexed citations
2.
Nakamura, Shunsuke, Satoshi Nagano, H. Nagao, et al.. (2013). Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation. PLoS ONE. 8(7). e69466–e69466. 62 indexed citations
3.
Baghdadi, Muhammad, Akihiro Yoneda, H. Nagao, et al.. (2013). TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance. Immunity. 39(6). 1070–1081. 104 indexed citations
4.
Baghdadi, Muhammad, H. Nagao, Hironori Yoshiyama, et al.. (2012). Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas. Cancer Immunology Immunotherapy. 62(4). 629–637. 44 indexed citations
5.
Nagao, H., Takao Setoguchi, Sho Kitamoto, et al.. (2012). RBPJ Is a Novel Target for Rhabdomyosarcoma Therapy. PLoS ONE. 7(7). e39268–e39268. 10 indexed citations
6.
Nagao, H., Kosei Ijiri, Masataka Hirotsu, et al.. (2011). Role of GLI2 in the growth of human osteosarcoma. The Journal of Pathology. 224(2). 169–179. 59 indexed citations
7.
Ijiri, Kosei, Yasuhiro Ishidou, Satoshi Nagano, et al.. (2011). Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1. PLoS ONE. 6(1). e16234–e16234. 22 indexed citations
8.
Hirotsu, Masataka, Takao Setoguchi, Hiromi Sasaki, et al.. (2010). Smoothened as a new therapeutic target for human osteosarcoma. Molecular Cancer. 9(1). 5–5. 93 indexed citations
9.
Hirotsu, Masataka, Takao Setoguchi, Hiromi Sasaki, et al.. (2009). Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. British Journal of Cancer. 101(12). 2030–2037. 35 indexed citations
10.
Nagao, H., Noriko Tachikawa, T Miki, et al.. (2002). Effect of recombinant human bone morphogenetic protein-2 on bone formation in alveolar ridge defects in dogs. International Journal of Oral and Maxillofacial Surgery. 31(1). 66–72. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026